Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Prostate cancer multifocality, the index lesion, and the microenvironment

Tourinho-Barbosa, Rafael R.a,b; de la Rosette, Jeanc,d; Sanchez-Salas, Rafaela

doi: 10.1097/MOU.0000000000000537
FOCAL THERAPY OF PROSTATE AND KIDNEY CANCER: Edited by Jean de la Rosette and Thomas J. Polascik

Purpose of review Most of focal therapies has addressed index lesion as the targeted tumour focus to treat localized prostate cancer (PCa), a multifocal disease. The interaction between tumour foci and host cells creates a tumour microenvironment (TME) which affects tumour growth, cellular proliferation, and PCa progression. This review aims to better understand the biology of cancer foci and their interaction with the prostatic microenvironment after focal therapy.

Recent findings Index lesions are representative of PCa grade in low-risk patients, but the other foci of tumour, the satellite lesions, gain relevance in higher risk patients. Multiparametric MRI, guided biopsies and new biomarkers in combination are important to address PCa multifocality and to adequately select patients to focal therapy. Stromal, immune, and tumoural components are integrated in tumourigenesis and modified after the inflammation induced by focal therapy.

Summary TME and inflammation play an important role in PCa progression, but further researches are necessary to understand how once protective components of prostate microenvironment become protumour elements and how inflammation induced by focal therapy can affect them. Learning how to modulate TME is an exploratory molecular field that can lead us to better manage PCa in both prevention and treatment scenarios.

aDepartment of Urology, Institut Mutualiste Montsouris, Université Paris-Descartes, Paris, France

bDepartment of Urology, Faculdade de Medicina do ABC (ABC Medical School), São Paulo, Brazil

cDepartment of Urology, Istanbul Medipol University, Istanbul, Turkey

dAcademic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Correspondence to Jean de la Rosette, MD, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. E-mail: J.J.Delarosette@amc.uva.nl

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.